Overview

Drug-drug Interaction Study With ASP1941 and Glimepiride

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
A study to investigate the effect of ASP1941 on the pharmacokinetics and safety of glimepiride (Part A) and to investigate the effect of glimepiride on the pharmacokinetics, safety and pharmacodynamics of ASP1941 (Part B).
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Glimepiride
Ipragliflozin